Equity Capital Markets

All filings · since 4 November 2002

Filings

Every share-offering filing on EDGAR since the day foreign issuers also had to file electronically. One row per filer: a filing made by a parent and its subsidiaries appears once for each of them, as in SEC's own index.

Page 1 · newest first · 50 per pageDownload as CSV (up to 5,000 rows)
FiledCompanyFilingAccession
2023-11-01
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-23-267738
2023-02-24
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-23-048395
2023-02-22
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-23-044169
2023-02-22
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 S-3ASRShelf registered0001193125-23-044140
2022-03-25
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-22-084189
2022-03-23
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-22-082865
2022-01-20
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-22-013844
2021-11-17
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-21-331991
2021-11-15
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-21-330175
2020-01-09
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-20-004806
2020-01-07
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-20-003041
2020-01-07
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 S-3ASRShelf registered0001193125-20-002991
2019-11-18
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 EFFECTDeclared effective9999999995-19-002593
2019-03-07
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-19-067261
2019-03-06
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 424B5Shelf takedown0001193125-19-065578
2018-12-28
Apellis Pharmaceuticals, Inc.
ShelfEffectiveCIK 1492422
 S-3ASRShelf registered0001193125-18-361002
2018-04-19
Apellis Pharmaceuticals, Inc.
Registered companyFinal prospectusCIK 1492422
 424B4Final prospectus0001193125-18-122634
2018-04-18
Apellis Pharmaceuticals, Inc.
Registered companyFinal prospectusCIK 1492422
 EFFECTDeclared effective9999999995-18-000858
2018-04-16
Apellis Pharmaceuticals, Inc.
Registered companyFinal prospectusCIK 1492422
 S-1Registration filed0001193125-18-118655
2018-04-03
Apellis Pharmaceuticals, Inc.
CIK 1492422
 DRSDraft made public0000950123-18-003316
2017-11-09
Apellis Pharmaceuticals, Inc.
IPOFinal prospectusCIK 1492422
 424B4Final prospectus0001193125-17-338588
2017-11-08
Apellis Pharmaceuticals, Inc.
IPOFinal prospectusCIK 1492422
 EFFECTDeclared effective9999999995-17-002925
2017-10-30
Apellis Pharmaceuticals, Inc.
IPOFinal prospectusCIK 1492422
 S-1/AAmendment0001193125-17-324222
2017-10-27
Apellis Pharmaceuticals, Inc.
IPOFinal prospectusCIK 1492422
 S-1/AAmendment0001193125-17-323102
2017-10-20
Apellis Pharmaceuticals, Inc.
IPOFinal prospectusCIK 1492422
 S-1/AAmendment0001193125-17-315537
2017-10-13
Apellis Pharmaceuticals, Inc.
IPOFinal prospectusCIK 1492422
 S-1Registration filed0001193125-17-309813
2017-08-30
Apellis Pharmaceuticals, Inc.
CIK 1492422
 DRSDraft made public0000950123-17-008317
2016-02-08
Apellis Pharmaceuticals, Inc.
First-time registrationWithdrawnCIK 1492422
 RWWithdrawn0001193125-16-453827
2015-11-02
Apellis Pharmaceuticals, Inc.
First-time registrationWithdrawnCIK 1492422
 S-1/AAmendment0001193125-15-362509
2015-10-13
Apellis Pharmaceuticals, Inc.
First-time registrationWithdrawnCIK 1492422
 S-1Registration filed0001193125-15-342824
2015-08-19
Apellis Pharmaceuticals, Inc.
CIK 1492422
 DRSDraft made public0000950123-15-009542